Breast cancer screening rates from January 2021 to October 2021 did not return to pre-pandemic levels, resulting in 27,000 missed colorectal cancer screenings, according to a new study.
In addition to the human toll of not detecting cancer early, when cancers are found at an advanced stage they are more extensive, more likely to spread to other parts of the body, and more difficult to treat, which leads to higher expense in treatment, the researchers pointed out.
See “Screening Rates for Breast, Cervical, and Colon Cancer Remain Below Pre-Pandemic Levels” by Christopher Cheney on the Health Leaders Media website (February 03, 2022)
See the short report “Troubling Cancer Screening Rates Still Seen Nearly Two Years Into the Pandemic” by Christopher Mast et al.
Related posts of interest
